In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL

Por Franssen, Remco, Schimmel, Alinda W. M., van Leuven, Sander I., Wolfkamp, Simone C. S., Stroes, Erik S. G., Dallinga-Thie, Geesje M.
Publicado em 2012

THE METABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS REVISITED; NEW PLAYERS, NEW INSIGHT

Por Dallinga-Thie, Geesje M., Franssen, Remco, Mooij, Hans L., Visser, Maartje E., Hassing, H. Carlijne, Peelman, Frank, Kastelein, John J.P., Péterfy, Miklós, Nieuwdorp, Max
Publicado em 2009

Chylomicronemia with Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects

Por Franssen, Remco, Young, Stephen G., Peelman, Frank, Hertecant, Jozef, Sierts, Jeroen A., Schimmel, Alinda W. M., Bensadoun, André, Kastelein, John J.P., Fong, Loren G., Dallinga-Thie, Geesje M., Beigneux, Anne P.
Publicado em 2010

In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1

Por Holleboom, Adriaan G., Jakulj, Lily, Franssen, Remco, Decaris, Julie, Vergeer, Menno, Koetsveld, Joris, Luchoomun, Jayraz, Glass, Alexander, Hellerstein, Marc K., Kastelein, John J. P., Hovingh, G. Kees, Kuivenhoven, Jan Albert, Groen, Albert K., Turner, Scott M., Stroes, Erik S. G.
Publicado em 2013

Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase

Por Beigneux, Anne P., Franssen, Remco, Bensadoun, André, Gin, Peter, Melford, Kristan, Peter, Jorge, Walzem, Rosemary L., Weinstein, Michael M., Davies, Brandon S.J., Kuivenhoven, Jan A., Kastelein, John J.P., Fong, Loren G., Dallinga-Thie, Geesje M., Young, Stephen G.
Publicado em 2009